Diabetes 52:2497-2502, 2003
© 2003 by the American Diabetes Association, Inc.
Variations in IB1/JIP1 Expression Regulate Susceptibility of ß-Cells to Cytokine-Induced Apoptosis Irrespective of C-Jun NH2-Terminal Kinase Signaling
Zhidong Ling1,
Mark Van de Casteele1,
Jing Dong1,
Harry Heimberg1,
Jacques-Antoine Haefliger2,
Gérard Waeber2,
Frans Schuit1, and
Daniel Pipeleers1
1 Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium
2 Department of Internal Medicine B, University Hospital, Lausanne, Switzerland
We previously reported that interleukin-1ß (IL-1ß) alone does not cause apoptosis of ß-cells, whereas when combined with -interferon (IFN- ) and tumor necrosis factor- (TNF- ), it exerts a distinct apoptotic effect. Studies in ß-cell lines indicated that IL-1ß reduced expression of islet brain (IB)-1/JNK interacting protein (JIP)-1, a JNK scaffold protein with antiapoptotic action. We examined whether variations in IB1/JIP-1 expression in purified primary ß-cells affect their susceptibility to cytokine-induced apoptosis. Exposure to IL-1ß for 24 h decreased cellular IB1/JIP-1 content by 66 ± 17%; this IL-1ß effect was maintained in the presence of TNF- + IFN- , which did not influence IB1/JIP-1 levels by themselves. Addition of IL-1ß to TNF- + IFN- increased apoptosis from 20 ± 2% to 59 ± 5%. A similar increase in TNF- + IFN- -induced apoptosis was produced by adenoviral expression of antisense IB1/JIP-1 and was not further enhanced by addition of IL-1ß, indicating that IL-1ß-mediated suppression of IB1/JIP-1 in ß-cells increases their susceptibility to cytokine-induced apoptosis. However, adenovirally mediated overexpression of IB1/JIP-1 also potentiated TNF- + IFN- -induced apoptosis, suggesting that the antiapoptotic effect of IB1/JIP-1 depends on well-defined cellular levels. We conclude that the IB1/JIP-1 level in ß-cells can control their susceptibility to apoptosis independent of JNK signaling.
Address correspondence and reprint requests to Zhidong Ling, Diabetes Research Center, Brussels Free University-VUB, Laarbeeklaan 103, B-1090 Brussels, Belgium. E-mail: zhidong.ling{at}vub.ac.be

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Ferdaoussi, S. Abdelli, J.-Y. Yang, M. Cornu, G. Niederhauser, D. Favre, C. Widmann, R. Regazzi, B. Thorens, G. Waeber, et al.
Exendin-4 Protects {beta}-Cells From Interleukin-1{beta}-Induced Apoptosis by Interfering With the c-Jun NH2-Terminal Kinase Pathway
Diabetes,
May 1, 2008;
57(5):
1205 - 1215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chen, X. Li, and P. N. Epstein
MnSOD and Catalase Transgenes Demonstrate That Protection of Islets From Oxidative Stress Does Not Alter Cytokine Toxicity
Diabetes,
May 1, 2005;
54(5):
1437 - 1446.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|